Navigation Links
New Word of Mouth Research Finds Moms Buzzing About Brands
Date:4/21/2008

BabyCenter(R)/Keller Fay study reveals pregnant and new moms have over 109 word of mouth conversations per week about products, services and brands

SAN FRANCISCO, April 21 /PRNewswire-FirstCall/ -- New research released today by BabyCenter(R), the largest online resource for expectant and new parents around the world, and industry-leading market research company, the Keller Fay Group, reveals that today's pregnant women and new moms engage in one-third more word of mouth conversations per day than the total public or women and almost two-thirds of these conversations include brand recommendations. This group has an average of 109 word of mouth conversations per week about products, services and brands, most of which are positive and considered highly credible by other moms.

The BabyCenter/Keller-Fay Word of Mouth Marketing Study, conducted in the first quarter of 2008, shows that 60 percent of conversations among this group carry with them a recommendation to buy, try or consider the brands under discussion and positive brand sentiment outweighs negative by a 10:1 margin. The credibility of word of mouth measured higher for pregnant and new moms than for the total U.S. public or women in every category measured. Among the mom segment, word of mouth about shopping, retail and apparel is highly impactful, with 69 percent likely to purchase based on what was heard.

The study showed that moms have much more on their minds than toys and car seats. Half or more of all moms surveyed report having at least one conversation per day about technology, financial services, health care, food/dining, media/entertainment, packaged goods, shopping and retail experiences. In fact, eight of the top ten most talked about brands listed in the study are retailer, consumer electronic or soft drink brands. On average, pregnant and new moms engage in seven conversations per week about technology and eight conversations per week about both beverages and shopping-re
'/>"/>

SOURCE BabyCenter
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mouth Swab May One Day Diagnose Lung Cancer
2. Mouth may tell the tale of lung damage caused by smoking
3. Monmouth Medical Center Performs New Incisionless Procedure to Treat Weight Regain After Gastric Bypass
4. Chronically Ill Patients Get More Care, Less Quality, Says Latest Dartmouth Atlas
5. Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy
6. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
7. Rural patients colon and lung cancers diagnosed earlier, Dartmouth research says
8. AUDIO from Medialink and P&G: New Tools for Promoting Good Mouth Health
9. Audio from Medialink and Philips: Americas Dirty Mouths
10. Healthy Weight Loss Begins With What You Permit to Enter Your Mind, More So Than Even Your Mouth!
11. Mouthpiece Could Help Ease Snoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...ill Discuss Best Practices in HCV and HIV Drug-Dis...l Drug Development Decision ... Pharsight,Corporation (Nasdaq: PHST ), a leading..., vice president and,lead scientist, Strategic Con...
...Understanding Not Confusion, FOLSOM, Calif., Feb...., CEO of California Walnut Commission: Given the s...r consumer understanding of healthy,food choices i...be confusing, our research says that people want m...
...or Health Solutions study finds anxiety over finan... a key issue in the upcoming ...erican consumers want more from,their health care ...r access to emerging innovations such as retail,cl...
... and techniques discussed at surgeons, conference,...n surgery patients are getting back on their feet ... The introduction of tissue graft products, bone a...han 1,000 foot,and ankle surgeons are learning abo...
..., Feb. 20 Varian Medical,Systems (NYSE: VAR ) is...,its revolutionary RapidArc(TM) radiotherapy techn...s. These symposia offer clinicians the opportunity...er than is possible with conventional IMRT or heli...
...ael, February 20 012,Smile.Communications (Nasdaq... fourth quarter results on Tuesday , February 26, ..., Management will host an interactive,teleconferen...800-994-4498 from within the U.S. or 1-888-604-583...
Other Medicine News:Health News:Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling 2Health News:Walnuts Rank High on New Nutrition Scales 2Health News:Walnuts Rank High on New Nutrition Scales 3Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 2Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 3Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 4Health News:Achilles Tendon Surgery Advances Speed Recovery 2Health News:Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments 2Health News:Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments 3Health News:012 Smile.Communication's Fourth Quarter Earnings Release and Conference Call Scheduled for February 26, 2008 2Health News:012 Smile.Communication's Fourth Quarter Earnings Release and Conference Call Scheduled for February 26, 2008 3
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 1FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 2Genital Herpes May Never Go Dormant 61659 1Genital Herpes May Never Go Dormant 61659 2Genital Herpes May Never Go Dormant 61659 3
...xpansion of Company,s Phase 3 Study for Wet AMD af...ata, FREMONT, Calif., April 17 NeoVista, Inc. an...ration (FDA) has granted the,company,s request to ...votal Phase 3 trial from 10 to 30 in the United St...ndary to AMD Treated with BEta RadiatioN,Epiretina...
...il 17 Innocoll, Inc., a privately-held,biopharmac...e planned phase,2 clinical trials sponsored by its...d, to investigate CollaRx(R) GENTAMICIN TOPICAL fo...c foot ulcers, has commenced,dosing. CollaRx GENTA...ble,Gentamicin-Collagen Sponge formulated and manu...
Other Medicine Technology:FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 4
...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
...ntation rate analysers, which are especially user-...well-established advantages of the existing analys...ch guarantee time-saving standardised analysis of ...ness is an essential aspect of daily recurrent rou...
Mix-Rate
Medicine Products: